000			01663 a2200421 4500
005			20250516083200.0
264		0	_c20120810
008			201208s 0 0 eng d
022			_a1873-3476
024	7		_a10.1016/j.ijpharm.2012.03.014 _2doi
040			_aNLM _beng _cNLM
100	1		_aLansakara-P, Dharmika S P
245	0	0	_aSynthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles. _h[electronic resource]
260			_bInternational journal of pharmaceutics _cJun 2012
300			_a123-34 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAntimetabolites, Antineoplastic _xchemical synthesis
650	0	4	_aCell Line, Tumor
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDeoxycytidine Kinase _xgenetics
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aEquilibrative Nucleoside Transporter 1 _xgenetics
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aLipids _xchemistry
650	0	4	_aMice
650	0	4	_aNanoparticles
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aRibonucleoside Diphosphate Reductase _xgenetics
650	0	4	_aTumor Suppressor Proteins _xgenetics
650	0	4	_aGemcitabine
700	1		_aRodriguez, B Leticia
700	1		_aCui, Zhengrong
773	0		_tInternational journal of pharmaceutics _gvol. 429 _gno. 1-2 _gp. 123-34
856	4	0	_uhttps://doi.org/10.1016/j.ijpharm.2012.03.014 _zAvailable from publisher's website
999			_c21630398 _d21630398